相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
Judith Wienke et al.
EUROPEAN JOURNAL OF CANCER (2021)
Therapeutic applications of AS1411 aptamer, an update review
Rezvan Yazdian-Robati et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models
Daniela Di Paolo et al.
SMALL (2020)
Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib
Diana Corallo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
Marie Wong et al.
NATURE MEDICINE (2020)
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
Emily Capone et al.
CANCERS (2020)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells
Fengfei Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers
Fabio Pastorino et al.
SMALL (2019)
Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands
Sofia Romano et al.
DRUG DISCOVERY TODAY (2019)
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
Jo Lynne Rokita et al.
CELL REPORTS (2019)
Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity
Joana Balca-Silva et al.
EXPERIMENTAL CELL RESEARCH (2018)
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2018)
Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles
Mirco Ponzoni et al.
SMALL (2018)
New perspectives of physiological and pathological functions of nucleolin (NCL)
Wenyu Jia et al.
LIFE SCIENCES (2017)
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature
Maud-Emmanuelle Gilles et al.
CANCER RESEARCH (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The roles of nucleolin subcellular localization in cancer
Caroline Madeleine Berger et al.
BIOCHIMIE (2015)
Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion
Irene Cossu et al.
BIOMATERIALS (2015)
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
Guendalina Zuccari et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches
Cristina Bottino et al.
FRONTIERS IN IMMUNOLOGY (2014)
Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
Jillian F. Wise et al.
BLOOD (2013)
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer
Vera Moura et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release
Damien Destouches et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Oncogenic Synergism between ErbB1, Nucleolin, and Mutant Ras
Keren Farin et al.
CANCER RESEARCH (2011)
Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
Daniela Di Paolo et al.
MOLECULAR THERAPY (2011)
Targeting a surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice
Diala El Khoury et al.
BMC CANCER (2010)
Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells
Wei Zhuo et al.
JOURNAL OF PATHOLOGY (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization
Ara G. Hovanessian et al.
PLOS ONE (2010)
Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
Fabio Pastorino et al.
CLINICAL CANCER RESEARCH (2008)
Identification of Nucleolin as New ErbB Receptors-Interacting Protein
Ayelet Di Segni et al.
PLOS ONE (2008)
Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status
Cynthia Winter et al.
PEDIATRIC BLOOD & CANCER (2008)
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin
Hubing Shi et al.
BLOOD (2007)
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
S Christian et al.
JOURNAL OF CELL BIOLOGY (2003)
The cell-surface-expressed nucleolin is associated with the actin cytoskeleton
AG Hovanessian et al.
EXPERIMENTAL CELL RESEARCH (2000)
分享论文
